ONPH most shares issued above current tax selling PPS NOTE 6: SHAREHOLDERS’ EQUITY:
On June 22, 2017 the Company issued 10,000,000 common shares to a note holder to reduce a note payable in the amount
of $1,000.
On November 20, 2018 the Company issued 5,000,000 of its common shares, to acquire the licensing rights to a proprietary
technology and intellectual property related to a method for activating immune cells for extracorporeal therapy
and related diagnostic uses, at cost of $0.01 per share or a total cost of $50,000. On the same date the Company agreed
to issue 100,000 common shares to each of six persons, comprising an advisory board concerning the aforementioned
licensing agreement, at a cost of $0.01 per shares or a total cost of $6000.
On February 20, 2019 the Company sold, for cash, 5,000,000 of its common shares, recorded at a cost of $5,000.
On March 1, 2019 an affiliate returned 58, 991,337 shares for cancelation.
On March 27, 2019 the Company issued 750,000 of its common shares to acquire the licensing rights to a proprietary
technology and intellectual property related to a drug delivery system being developed to target a variety of cancers and
other diseases.
On March 27, 2019 the Company issued 625,000 of its common shares to settle a dispute with an affiliate. The shares
were recorded at a cost of $0.0222 per share.
During the year ended March 31, 2019 the Company issued 56,100,000 of its common shares to nine consultants and
advisory board members at costs ranging from $0.01 per share to $0.024 per share for a total cost of $765,680.
On July 16, 2019, the Company issued 100,000 of its common shares to a consultant and advisory board member at a cost
of $0.0091 per shares.
On August 26, 2019, the Company issued 2,500,000 of its common shares to acquire the licensing rights to a proprietary
technology and intellectual property related to producing a treatment for human and animal cancer, recorded at a cost of
$0.05 per share.
On September 17, 2019 the Company issued 8,500,000 of its common shares to an individual for consulting services,
recorded at a cost of $0.0297 per share.
